| Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study NM Kuderer, TK Choueiri, DP Shah, Y Shyr, SM Rubinstein, DR Rivera, ... The Lancet 395 (10241), 1907-1918, 2020 | 1828 | 2020 |
| Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium P Grivas, AR Khaki, TM Wise-Draper, B French, C Hennessy, CY Hsu, ... Annals of oncology 32 (6), 787-800, 2021 | 287 | 2021 |
| Association of convalescent plasma therapy with survival in patients with hematologic cancers and COVID-19 MA Thompson, JP Henderson, PK Shah, SM Rubinstein, MJ Joyner, ... JAMA oncology 7 (8), 1167-1175, 2021 | 169 | 2021 |
| Phase II clinical trial of neoadjuvant and adjuvant pembrolizumab in resectable local–regionally advanced head and neck squamous cell carcinoma TM Wise-Draper, S Gulati, S Palackdharry, BH Hinrichs, FP Worden, ... Clinical Cancer Research 28 (7), 1345-1352, 2022 | 52 | 2022 |
| Racial disparities in COVID-19 outcomes among black and white patients with cancer J Fu, SA Reid, B French, C Hennessy, C Hwang, NT Gatson, N Duma, ... JAMA network open 5 (3), e224304-e224304, 2022 | 46 | 2022 |
| Current state of systemic therapies for advanced renal cell carcinoma S Gulati, U Vaishampayan Current Oncology Reports 22, 1-10, 2020 | 45 | 2020 |
| COVID‐19 pandemic and impact on cancer clinical trials: An academic medical center perspective M Marcum, N Kurtzweil, C Vollmer, L Schmid, A Vollmer, A Kastl, K Acker, ... Cancer medicine 9 (17), 6141-6146, 2020 | 39 | 2020 |
| Lupus anticoagulant and ANCA associated thrombotic vasculopathy due to cocaine contaminated with levamisole: a case report and review of the literature S Gulati, AA Donato Journal of thrombosis and thrombolysis 34, 7-10, 2012 | 39 | 2012 |
| Association between androgen deprivation therapy and mortality among patients with prostate cancer and COVID-19 AL Schmidt, MD Tucker, Z Bakouny, C Labaki, CY Hsu, Y Shyr, ... JAMA network open 4 (11), e2134330-e2134330, 2021 | 38 | 2021 |
| Phase 1 dose‐finding study of metformin in combination with concurrent cisplatin and radiotherapy in patients with locally advanced head and neck squamous cell cancer S Gulati, J Desai, SM Palackdharry, JC Morris, Z Zhu, R Jandarov, ... Cancer 126 (2), 354-362, 2020 | 37 | 2020 |
| Interplay of immunosuppression and immunotherapy among patients with cancer and COVID-19 Z Bakouny, C Labaki, P Grover, J Awosika, S Gulati, CY Hsu, ... JAMA oncology 9 (1), 128-134, 2023 | 30 | 2023 |
| LBA71 systemic cancer treatment-related outcomes in patients with SARS-CoV-2 infection: a CCC19 registry analysis TM Wise-Draper, A Desai, A Elkrief, BI Rini, DB Flora, DW Bowles, ... Annals of Oncology 31, S1201-S1202, 2020 | 30 | 2020 |
| Metformin increases natural killer cell functions in head and neck squamous cell carcinoma through CXCL1 inhibition MK Crist, B Yaniv, S Palackdharry, MA Lehn, M Medvedovic, T Stone, ... Journal for immunotherapy of cancer 10 (11), 2022 | 29 | 2022 |
| The CoVID‐TE risk assessment model for venous thromboembolism in hospitalized patients with cancer and COVID‐19 A Li, NM Kuderer, CY Hsu, Y Shyr, JL Warner, DP Shah, V Kumar, S Shah, ... Journal of thrombosis and haemostasis 19 (10), 2522-2532, 2021 | 28 | 2021 |
| Advanced biliary tract cancer: clinical outcomes with ABC-02 regimen and analysis of prognostic factors in a tertiary care center in the United States R Agarwal, A Sendilnathan, NI Siddiqi, S Gulati, A Ghose, C Xie, ... Journal of gastrointestinal oncology 7 (6), 996, 2016 | 23 | 2016 |
| Biomarkers in renal cell carcinoma: Are we there yet? S Gulati, NJ Vogelzang Asian journal of urology 8 (4), 362-375, 2021 | 20 | 2021 |
| Evolving treatment paradigm in metastatic non clear cell renal cell carcinoma S Gulati, E Philip, S Salgia, SK Pal Cancer Treatment and Research Communications 23, 100172, 2020 | 20 | 2020 |
| Geriatric risk factors for serious COVID-19 outcomes among older adults with cancer: a cohort study from the COVID-19 and Cancer Consortium A Elkrief, C Hennessy, NM Kuderer, SM Rubinstein, E Wulff-Burchfield, ... The Lancet Healthy Longevity 3 (3), e143-e152, 2022 | 19 | 2022 |
| First-line treatments for metastatic clear cell renal cell carcinoma: an ever-enlarging landscape S Gulati, C Labaki, GS Karachaliou, TK Choueiri, T Zhang The oncologist 27 (2), 125-134, 2022 | 18 | 2022 |
| Assessing population diversity in phase III trials of cancer drugs supporting Food and Drug Administration approval in solid tumors E Yekedüz, D Trapani, W Xu, EGE de Vries, C Labaki, B Gyawali, S Gulati, ... International journal of cancer 149 (7), 1455-1462, 2021 | 18 | 2021 |
